Cellectis Sa Stock Market Value
| CLLS Stock | USD 1.84 0.02 1.10% |
| Symbol | Cellectis |
Cellectis SA Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectis. If investors know Cellectis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.851 | Return On Assets | Return On Equity |
The market value of Cellectis SA is measured differently than its book value, which is the value of Cellectis that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectis' value that differs from its market value or its book value, called intrinsic value, which is Cellectis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectis' market value can be influenced by many factors that don't directly affect Cellectis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cellectis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectis.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in Cellectis on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding Cellectis SA or generate 0.0% return on investment in Cellectis over 90 days. Cellectis is related to or competes with Innate Pharma, Genfit SA, MeiraGTx Holdings, C4 Therapeutics, Fate Therapeutics, Adaptimmune Therapeutics, and Atara Biotherapeutics. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cell... More
Cellectis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectis SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.18 | |||
| Information Ratio | 0.0517 | |||
| Maximum Drawdown | 40.91 | |||
| Value At Risk | (4.83) | |||
| Potential Upside | 5.8 |
Cellectis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectis' standard deviation. In reality, there are many statistical measures that can use Cellectis historical prices to predict the future Cellectis' volatility.| Risk Adjusted Performance | 0.081 | |||
| Jensen Alpha | 0.298 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0871 | |||
| Treynor Ratio | 0.4855 |
Cellectis SA Backtested Returns
Cellectis appears to be very risky, given 3 months investment horizon. Cellectis SA secures Sharpe Ratio (or Efficiency) of 0.0929, which signifies that the company had a 0.0929 % return per unit of risk over the last 3 months. By analyzing Cellectis' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Cellectis' Mean Deviation of 3.1, risk adjusted performance of 0.081, and Downside Deviation of 3.18 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cellectis holds a performance score of 7. The firm shows a Beta (market volatility) of 0.84, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cellectis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellectis is expected to be smaller as well. Please check Cellectis' downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Cellectis' price patterns will revert.
Auto-correlation | -0.55 |
Good reverse predictability
Cellectis SA has good reverse predictability. Overlapping area represents the amount of predictability between Cellectis time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectis SA price movement. The serial correlation of -0.55 indicates that about 55.0% of current Cellectis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Cellectis SA lagged returns against current returns
Autocorrelation, which is Cellectis stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cellectis' stock expected returns. We can calculate the autocorrelation of Cellectis returns to help us make a trade decision. For example, suppose you find that Cellectis has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cellectis regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cellectis stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cellectis stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cellectis stock over time.
Current vs Lagged Prices |
| Timeline |
Cellectis Lagged Returns
When evaluating Cellectis' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cellectis stock have on its future price. Cellectis autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cellectis autocorrelation shows the relationship between Cellectis stock current value and its past values and can show if there is a momentum factor associated with investing in Cellectis SA.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.